Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection.

AIM--To evaluate the histological changes that occur in the antral mucosa of healthy male subjects before and after one week of naproxen administration, using a chemical gastritis score according to the Helicobacter pylori status. METHODS--Nineteen male subjects (mean age 31 years) underwent two endoscopies: one before and the other after one week of naproxen treatment (1 g daily). Antral biopsy specimens were assessed for the presence of H pylori infection and for chemical gastritis, defined as the presence of foveolar hyperplasia, muscle fibres in the lamina propria, oedema, and vasodilatation, in the absence of acute or chronic inflammatory cell infiltrate. RESULTS--Of the 19 subjects, eight had H pylori infection. After one week of naproxen treatment, none of those with H pylori infection developed chemical gastritis, while five of 11 (45%) of those without H pylori infection did. In the absence of H pylori infection there was no evidence of inflammation, either before or after naproxen administration. CONCLUSIONS--A different pattern of antral histological change occurs following naproxen administration. This pattern is related to the presence or absence of H pylori infection, suggesting that H pylori status should be determined in histological studies of subjects taking non-steroidal anti-inflammatory drugs.

[1]  A. Price,et al.  Gastritis in patients on non‐steroidal anti‐inflammatory drugs , 1993, Histopathology.

[2]  R. Russell,et al.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. , 1993, Gut.

[3]  A. Zinsmeister,et al.  Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. , 1992, Gastroenterology.

[4]  I. Nakshabendi,et al.  Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration. , 1992, Journal of clinical pathology.

[5]  D. Graham,et al.  Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. , 1991, The American journal of gastroenterology.

[6]  D. Graham,et al.  Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. , 1991, Gastroenterology.

[7]  D. M. Jones,et al.  Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. , 1991, British journal of rheumatology.

[8]  R. Russell,et al.  The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro , 1990, Alimentary pharmacology & therapeutics.

[9]  M. Falzon,et al.  Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful? , 1990, The American journal of gastroenterology.

[10]  A. Axon,et al.  Reflux gastritis in the intact stomach. , 1990, Journal of clinical pathology.

[11]  Edward L. Lee,et al.  Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin. , 1988, Gastroenterology.

[12]  R. Russell,et al.  Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs. , 1988, British journal of rheumatology.

[13]  A. Axon,et al.  Reflux gastritis: distinct histopathological entity? , 1986, Journal of clinical pathology.

[14]  R. Nelson,et al.  Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. , 1980, The New England journal of medicine.

[15]  G. Sobala,et al.  Reflux gastritis intheintact stomach , 1990 .